KPV 10mg

KPV – 10 mg

KPV is a synthetic tripeptide fragment derived from the C-terminal end of the melanocortin peptide α-MSH. It has been widely studied in preclinical research for its potent anti-inflammatory, immunomodulatory, and tissue-protective properties. Due to its stability and small molecular size, KPV has become a molecule of interest in models involving epithelial repair, gut barrier function, and inflammatory regulation.

In laboratory settings, KPV is frequently evaluated for its ability to reduce pro-inflammatory cytokines, promote mucosal healing, and support systems affected by inflammation-driven stress.

Mechanism of Action (Based on Preclinical Research):

• Melanocortin pathway interaction: Acts on melanocortin receptors, particularly MC1R, contributing to anti-inflammatory signaling.

• Cytokine suppression: Demonstrates the ability to inhibit pro-inflammatory mediators such as TNF-α, IL-6, and NF-κB pathways.

• Epithelial protection and repair: Studied for supporting the integrity of epithelial barriers, including gut and skin tissues.

• Antimicrobial modulation: Shows potential involvement in reducing inflammatory responses to microbial stressors.

Potential Benefits (Based on Preclinical Research):

• May reduce inflammation in various tissue models

• Supports epithelial and mucosal repair, including gastrointestinal lining

• Potentially beneficial in immune modulation and inflammatory regulation

• Evaluated for reducing pain and local irritation associated with inflammation

• Explored for applications in skin repair, wound environments, and barrier protection

⚠️ For Research Use Only. Not for Human Consumption.
This compound is not approved by the FDA or any other regulatory authority and is intended solely for laboratory research.